Imvax is Drug Discovery in United States that focus on immunotherapy strategies business. Founded in 2015. They cover business area such as developer, patient-specific vaccine, immunotherapy strategy, malignant glioma, unmet medical need, an autologous tumor cell vaccine, a multi-pronged response, physician, brain tumor.
2015
( 9 years old in 2024 )
Immunotherapy Strategies
-
601 Walnut Street
Suite 440 West
Philadelphia, PA 19106
United States
Private
developerpatient-specific vaccineimmunotherapy strategymalignant gliomaunmet medical needan autologous tumor cell vaccinea multi-pronged responsephysicianbrain tumor
* We use standard office opening hours in near Imvax's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Imvax is Drug Discovery business from United States that founded in 2015 (9 years old in 2024), Imvax business is focusing on Immunotherapy Strategies.
Imvax headquarter office and corporate office address is located in 601 Walnut Street Suite 440 West Philadelphia, PA 19106 United States.
Imvax was founded in United States.
In 2024, Imvax is currently focus on immunotherapy strategies sector.
Above is snippet of Google Trends for "immunotherapy strategies" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Imvax, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
